Programmed Colorectal Cancer Screening Decreases Incidence and Mortality

Overview

Journal Transl Gastroenterol Hepatol

Publisher AME Publishing Company

Specialty Gastroenterology

Date 2020 Feb 11

PMID 32039289

Citations 10

Authors

Susana Rosello

Soraya Simon

Andres Cervantes

Affiliations

Soon will be listed here.

Citing Articles

Association between time to colonoscopy after positive fecal testing and colorectal cancer outcomes in Alberta, Canada.

Brenner D, Carbonell C, Xu L, Nemecek N, Yang H J Med Screen. 2024; 31(4):232-238.

PMID: 38486492 PMC: 11526417. DOI: 10.1177/09691413241239023.

16S rRNA sequencing analysis of the oral and fecal microbiota in colorectal cancer positives versus colorectal cancer negatives in Iranian population.

Rezasoltani S, Azizmohammad Looha M, Aghdaei H, Jasemi S, Sechi L, Gazouli M Gut Pathog. 2024; 16(1):9.

PMID: 38378690 PMC: 10880352. DOI: 10.1186/s13099-024-00604-0.

miR-6883 downregulates HIF1α in colorectal and breast cancer cells.

Jensen-Velez N, Carlsen L, El-Deiry W MicroPubl Biol. 2024; 2024.

PMID: 38344066 PMC: 10853816. DOI: 10.17912/micropub.biology.000978.

Patients' Expectations and Preferences for the Organizational Conditions of the Colorectal Cancer Screening Programme in Poland: A Qualitative Analysis.

Gac A, Kedzior K, Pogorzelczyk K, Wojtecka A, Wojnarowska M, Robakowska M Healthcare (Basel). 2023; 11(3).

PMID: 36766948 PMC: 9914256. DOI: 10.3390/healthcare11030371.

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.

Wisse P, de Klaver W, van Wifferen F, Meiqari L, Bierkens M, Greuter M BMC Cancer. 2022; 22(1):1299.

PMID: 36503495 PMC: 9743627. DOI: 10.1186/s12885-022-10372-2.

References

Knudsen A, Zauber A, Rutter C, Naber S, Doria-Rose V, Pabiniak C . Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force. JAMA. 2016; 315(23):2595-609. PMC: 5493310. DOI: 10.1001/jama.2016.6828. View

Levin T, Corley D, Jensen C, Schottinger J, Quinn V, Zauber A . Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population. Gastroenterology. 2018; 155(5):1383-1391.e5. PMC: 6240353. DOI: 10.1053/j.gastro.2018.07.017. View

Basu P, Ponti A, Anttila A, Ronco G, Senore C, Vale D . Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report. Int J Cancer. 2017; 142(1):44-56. DOI: 10.1002/ijc.31043. View

Chukmaitov A, Bradley C, Dahman B, Siangphoe U, Warren J, Klabunde C . Association of polypectomy techniques, endoscopist volume, and facility type with colonoscopy complications. Gastrointest Endosc. 2013; 77(3):436-46. PMC: 4857725. DOI: 10.1016/j.gie.2012.11.012. View

Welch H, Robertson D . Colorectal Cancer on the Decline--Why Screening Can't Explain It All. N Engl J Med. 2016; 374(17):1605-7. DOI: 10.1056/NEJMp1600448. View

Hol L, Wilschut J, van Ballegooijen M, van Vuuren A, van der Valk H, Reijerink J . Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer. 2009; 100(7):1103-10. PMC: 2670000. DOI: 10.1038/sj.bjc.6604961. View

Tinmouth J, Lansdorp-Vogelaar I, Allison J . Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Gut. 2015; 64(8):1327-37. DOI: 10.1136/gutjnl-2014-308074. View

Kirkoen B, Berstad P, Botteri E, Avitsland T, Ossum A, de Lange T . Do no harm: no psychological harm from colorectal cancer screening. Br J Cancer. 2016; 114(5):497-504. PMC: 4782205. DOI: 10.1038/bjc.2016.14. View

Peterse E, Meester R, Siegel R, Chen J, Dwyer A, Ahnen D . The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline. Cancer. 2018; 124(14):2964-2973. PMC: 6033623. DOI: 10.1002/cncr.31543. View

10.

Bhandari A, Woodhouse M, Gupta S . Colorectal cancer is a leading cause of cancer incidence and mortality among adults younger than 50 years in the USA: a SEER-based analysis with comparison to other young-onset cancers. J Investig Med. 2016; 65(2):311-315. PMC: 5564445. DOI: 10.1136/jim-2016-000229. View

11.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

12.

Schreuders E, Ruco A, Rabeneck L, Schoen R, Sung J, Young G . Colorectal cancer screening: a global overview of existing programmes. Gut. 2015; 64(10):1637-49. DOI: 10.1136/gutjnl-2014-309086. View

13.

Vermeer N, Snijders H, Holman F, Liefers G, Bastiaannet E, van de Velde C . Colorectal cancer screening: Systematic review of screen-related morbidity and mortality. Cancer Treat Rev. 2017; 54:87-98. DOI: 10.1016/j.ctrv.2017.02.002. View

14.

Walter L, Covinsky K . Cancer screening in elderly patients: a framework for individualized decision making. JAMA. 2001; 285(21):2750-6. DOI: 10.1001/jama.285.21.2750. View

15.

Lin J, Piper M, Perdue L, Rutter C, Webber E, OConnor E . Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2016; 315(23):2576-94. DOI: 10.1001/jama.2016.3332. View

16.

Rabeneck L, Rumble R, Thompson F, Mills M, Oleschuk C, Whibley A . Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening. Can J Gastroenterol. 2012; 26(3):131-47. PMC: 3299236. DOI: 10.1155/2012/486328. View

17.

Lauby-Secretan B, Vilahur N, Bianchini F, Guha N, Straif K . The IARC Perspective on Colorectal Cancer Screening. N Engl J Med. 2018; 378(18):1734-1740. PMC: 6709879. DOI: 10.1056/NEJMsr1714643. View

18.

Brenner H, Stock C, Hoffmeister M . Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ. 2014; 348:g2467. PMC: 3980789. DOI: 10.1136/bmj.g2467. View

19.

Rex D, Boland C, Dominitz J, Giardiello F, Johnson D, Kaltenbach T . Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017; 112(7):1016-1030. DOI: 10.1038/ajg.2017.174. View

20.

Meester R, Doubeni C, Zauber A, Goede S, Levin T, Corley D . Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015; 121(13):2281-5. PMC: 4567966. DOI: 10.1002/cncr.29336. View